Nuphos 200 Injection
Marketer
Zee Laboratories
Salt Composition
Cyclophosphamide (200mg)
Overview Nuphos 200 Injection
Inonphos 200 Injection combats various cancers and serves as a treatment for childhood nephrotic syndrome when other therapies prove ineffective. Its application may extend to other conditions as directed by a physician. Administered intravenously by a healthcare provider, ideally at the same time daily, the dosage and frequency are determined by your doctor based on your specific condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdosage can result in severe adverse reactions. While benefits may not be immediately apparent (weeks or months), discontinuation should only occur under medical supervision. Common side effects, such as nausea, vomiting, alopecia, pyrexia, and hematuria, should be reported if persistent or worsening; mitigating strategies may be available. As a potent medication, serious side effects are possible. Immunosuppression, hematological, hepatic, and renal complications are potential risks, necessitating regular blood monitoring. Increased fluid intake to promote diuresis is recommended to minimize genitourinary complications and maintain renal function. Prior to commencement, disclose any existing hepatic or renal impairment, or concurrent use of antimicrobial agents. Interactions with other medications are possible; therefore, comprehensive medication disclosure is vital. This injection is contraindicated during pregnancy and lactation; reliable contraception for both partners is strongly advised throughout the treatment period.
Primary Ingredients of Nuphos 200 Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Nuphos 200 Injection
Malignancy | Nephrotic syndrome
Major Benefits of Nuphos 200 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Nuphos 200 Injection:
- Vomiting
- Nausea
- Hair loss
- Fever
- Blood in urine
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Nuphos 200 Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
How Nuphos 200 Injection works:
Nuphos 200 Injection is a cancer treatment utilizing alkylation. Its mechanism involves disrupting the DNA and RNA of malignant cells, thus inhibiting their proliferation and growth, effectively combating cancerous tumors.
SAFETY ADVICE
AlcoholUNSAFE
Combining Nuphos 200 Injection and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Nuphos 200 Injection during pregnancy carries a confirmed risk to the fetus. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice.
Breast feedingUNSAFE
Administering Nuphos 200 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Nuphos 200 Injection might induce adverse reactions, potentially impairing driving capabilities. These reactions can include dizziness, blurred vision, or visual disturbances, all of which may negatively impact the ability to operate a vehicle safely.
KidneyCAUTION
For individuals with severe kidney impairment, administration of Nuphos 200 Injection requires careful monitoring. Dosage modification of Nuphos 200 Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Nuphos 200 Injection. Dosage modification for Nuphos 200 Injection might be necessary. Physician consultation is advised.
What if you forget to take Nuphos 200 Injection :
NA
Facts to Know About Nuphos 200 Injection
| Label | Value |
|---|---|
| Chemical Type | Nitrogen Mustard Agents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Alkylating substance |
3,018 People bought this recently